Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype

Peter Solar, Laurie Feldman, Jee Yeong Jeong, Jacqueline R. Busingye, Arthur J. Sytkowski

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint Dive into the research topics of 'Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype'. Together they form a unique fingerprint.

Medicine & Life Sciences